The variable expression patterns of MUC2 (i.e., marker for intestinal metaplasia) and MUC4 (i.e., marker for spasmolytic polypeptide expressing metaplasia (SPEM)) seen in the adjacent non-tumor tissues suggest the presence of metaplastic changes in these peritumoral sites [44, 45]. This evidence concerns the gene MUC2 and neoplasm.